Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-027812
Filing Date
2025-02-26
Accepted
2025-02-26 16:30:45
Documents
15
Effectiveness Date
2025-02-26

Document Format Files

Seq Description Document Type Size
1 S-8 rlay-20250226.htm S-8 131236
2 EX-5.1 rlay-ex5_1.htm EX-5.1 13170
3 EX-23.1 rlay-ex23_1.htm EX-23.1 3999
4 EX-FILING FEES rlay_exfilingfees.htm   iXBRL EX-FILING FEES 57674
  Complete submission text file 0000950170-25-027812.txt   363891

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT rlay_exfilingfees_htm.xml XML 16336
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285281 | Film No.: 25670637
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)